Skip to content

Welcome

Thank you for visiting Servier’s Medical Congress Newsroom to learn more about our presence at this year’s American Society of Hematology (ASH) Annual Meeting.

At Servier, we’re committed to unlocking the potential of targeted therapies, by better understanding genetic mutations that drive blood cancers, helping ensure every patient receives the right treatment at the right time.

Resources

Accepted Abstracts

Accepted Abstracts

News Release

News Release

About IDH Mutations

About IDH Mutations